Mefatinib-d6 (free base)

• UNSPSC Description:

  Mefatinib-d6 free base (Mifanertinib-d6) is the deuterium labeled Mefatinib. Mefatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1].

• Target Antigen:

  c-Met/HGFR; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC1=CC2=C(NC3=CC=C(C(Cl)=C3)F)N=CN=C2C=C1OC(F)F)/C=C/CN(C([2H])([2H])[2H])C([2H])([2H])[2H]

• Molecular Weight:

  471.89

• References & Citations:

  [1]WHO Drug Information-World Health Organization (WHO).

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported